19 Matching Annotations
  1. Aug 2026
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13430211/
  3. Jul 2026
  4. 54.241.53.176 54.241.53.176
    1-s2.0-S2473952926004866-main (1)-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    54.241.53.176/2b72daef531c88fbc1f7b7b1bffe93d2645aa9af/1-s2.0-S2473952926004866-main (1)-html.html
  5. May 2026
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609)
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13176817/
  7. aacrjournals.org aacrjournals.org
    Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 Study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/6/3/673/776487/Lenvatinib-plus-Pembrolizumab-for-Patients-with
  8. Apr 2026
  9. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Cancer Treatment-related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13101912/
  10. aacrjournals.org aacrjournals.org
    Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid Tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/5/9/1664/765343/Phase-2-Study-of-Zilovertamab-Vedotin-in
  11. Mar 2026
  12. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12967298/
  13. Nov 2025
  14. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12580772/
  15. Sep 2025
  16. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Cemiplimab in locally advanced or metastatic secondary angiosarcomas (CEMangio): A phase II clinical trial and biomarker analyses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12402795/
  17. Jun 2025
  18. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/22f68322b948f74711c059b254f94e963af26ed4/PDF-html.html
  19. Apr 2025
  20. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11964177/
  21. Feb 2025
  22. aacrjournals.org aacrjournals.org
    Safety and efficacy of irradiation boost based on 18F-FET-PET in patients with newly diagnosed glioblastoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/28/14/3011/706875/Safety-and-Efficacy-of-Irradiation-Boost-Based-on
  23. Apr 2024
  24. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10982638/
  25. Feb 2024
  26. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10524118/
  27. Dec 2023
  28. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase 1b Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10722139/
  29. 52.53.155.43 52.53.155.43
    ccr-23-0229-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/ff14fa8c7ad9abea8294fa337473afc457723345/ccr-23-0229-html.html
  30. Jan 2023
  31. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9377723/
  32. Aug 2022
  33. 52.53.155.43 52.53.155.43
    ccr-22-0171-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/975ed7699dc7d65ad528cb06c61b931c16326360/3011-html.html
  34. Jun 2022
  35. 52.53.155.43 52.53.155.43
    ccr-22-0171-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/975ed7699dc7d65ad528cb06c61b931c16326360/3011-html.html